The Role of Prophylactic Antibiotic in MRSA

download The Role of Prophylactic Antibiotic in MRSA

of 19

Transcript of The Role of Prophylactic Antibiotic in MRSA

  • 8/2/2019 The Role of Prophylactic Antibiotic in MRSA

    1/19

    The Role of ProphylacticAntibiotics in Open Fractures

    in an Era of Community acquired

    Methicillin-resistantStaphylococcus aureus

    CARLA C. SAVELI, MD; ROBERT W. BELKNAP, MD;

    STEVEN J. MORGAN, MD; CONNIE S. PRICE, MD

  • 8/2/2019 The Role of Prophylactic Antibiotic in MRSA

    2/19

    ABSTRACT Infection is a feared complication and a

    common cause of loss of function following

    open fractures. Staphylococcus aureus, the most common

    cause of surgical site infection in patients withopen fractures. Although widespreademergence of

    methicillinresistantStaphylococcus aureus(MRSA) has been described in both hospitaland community settings

  • 8/2/2019 The Role of Prophylactic Antibiotic in MRSA

    3/19

    Open fractures are characterized by softtissue disruption that results in

    communication of the fracture site withthe outside environment.

  • 8/2/2019 The Role of Prophylactic Antibiotic in MRSA

    4/19

    DATA SOURCES

    computerized bibliographic search usingthe databases PubMed, Medline from

    1950 to 2009 and Embase from 1980 to2009 for English language studies.

    United States PreventiveServices TaskForce to stratify the quality of evidence.

  • 8/2/2019 The Role of Prophylactic Antibiotic in MRSA

    5/19

    7 studies eligible as Level-I evidence were

    analyzed for antibiotic selection, timingandduration for prophylaxis in open fractures

    Thirteen articles were reviewed andreferred to as evidence for theemergence of MRSA

    in orthopedic trauma patients.

  • 8/2/2019 The Role of Prophylactic Antibiotic in MRSA

    6/19

    DATA SUPPORTING CURRENT

    PROPHYLAXISRECOMMENDATIONS

    In 1974, Patzakis et al6 demonstrated

    a reduction of infections in patients withopen fracture wounds

    Cephalothin,, was demonstrated to

    be superior to both no antibiotics and to

    a regimen of penicillin and streptomycin.

  • 8/2/2019 The Role of Prophylactic Antibiotic in MRSA

    7/19

    Bergman, in 1982, demonstrated asignificant decrease in both superficial

    and deep wound infection in openfractures with severe soft tissue injury withthe administration of perioperativedicloxacillin compared with placebo.

  • 8/2/2019 The Role of Prophylactic Antibiotic in MRSA

    8/19

    The current quality standard for themanagement of open fractures includes

    the administration of parenteral antibioticprophylaxis with an effective regimenconsisting of a first generationcephalosporin

  • 8/2/2019 The Role of Prophylactic Antibiotic in MRSA

    9/19

    In a 1999 double-blind controlled trial byCarsenti-Etesse et al, 616 patients with

    open tibial fracture requiring openreduction and internal fixation wererandomized to receive pefloxacin versuscefazolin after their fracture and assessed

    for surgical site infection within3 months

  • 8/2/2019 The Role of Prophylactic Antibiotic in MRSA

    10/19

    Summary of Trials Cited in This Review as Level I

    Evidence on Antibiotic Prophylaxis After OpenFractures

    Year 1974 1982 1987 1988 1999

    Author Patzakis

    et al

    Berman Braun et al Dellinger

    et al

    Carsenti-

    Etesse et

    al

    Methods RTC RTC-DB RTC-DB RTC-DB RTC-DB

    No. ofpatients

    310 90 87 248 616

    Prophylact

    ic

    antibiotic

    regimen

    Group I

    (79): no

    antibiotics.

    Group

    II (92): PCNstreptomy

    cin for 10

    d. Group

    III (84):

    cephalothi

    n for 10 d

    Group I:

    Placebo

    (30) -

    saline.

    GroupII: (60) -

    PCN or

    dicloxaciln

    for 2 d

    Group I:

    Indistinguis

    hable

    placebo

    44). GroupII:

    Experimen

    tal

    (43)

    cloxacillin

    for 6 d

    Group I

    (79):

    Cefonicid

    for 1 d.

    GroupII (85):

    Cefonicid

    for 5 d.

    Group III

    (84):

    Cefaman

    dol

    Group I

    (316):

    Pefl

    oxacin

    singledose.

    Group II

    (300):

    Ceftazolin

    for 2 d

    followed

    by

  • 8/2/2019 The Role of Prophylactic Antibiotic in MRSA

    11/19

    End point Early clinicalwoundinfection witheithera positive gramstain or apositive

    culture

    Early woundinfection:Sub classifiedAs superficial ordeep

    Early woundinfection:woundinspection &swabsat weeklyintervals

    during thepostoperativecourse

    Cellulitis,superficialor deepwoundinfections

    Early woundinfection

    Length offollow-up

    Not specifi ed Until woundshealed

    Not specifi ed 6 mo 3 mo

    Outcome Group III hadsignificantlylower infectionsrate (2.3%)compared withGroup I(13.9%).No significantdifference

    betweenGroup I & II

    Group II hadsignificantlylower infectionrate comparedwith Group I

    Group II hadsignificantlylower infectionrate (4.6%)compared withGroup I (27.2%)

    No significantdifferencebetween the 3groups

    No significantdifferencebetweenthe 2 groups(7%vs 8% P.51). Nodifference intheproportion of

    gram negativeSSI

    Leading causeof SSI

    Staphylococus

    aureusStaphylococcu

    s

    aureus

    Staphylococcu

    s

    aureus

    Staphylococcu

    s

    aureus

    Staphylococcu

    s

    aureus.Methicillinresistant

    Staphylococcus

  • 8/2/2019 The Role of Prophylactic Antibiotic in MRSA

    12/19

    Timing and Duration of

    ProphylacticAntibiotics

    Patzakis and Wilkins demonstrated aclear benefit if antibiotics are given within

    3 hours after the injury with a rate ofinfection of 4.7% compared with a rate of7.4% if antibiotics were delayed for 3hours.

  • 8/2/2019 The Role of Prophylactic Antibiotic in MRSA

    13/19

    the current guidelines recommend theadministration of prophylactic antibiotics

    within 3 hours of the injury until 24 hoursafter the surgical intervention. Additionalprophylaxis for 24 hours is recommendedfor subsequent interventions in the same

    surgical area.

    EMERGENCE OF MRSA AS A

  • 8/2/2019 The Role of Prophylactic Antibiotic in MRSA

    14/19

    EMERGENCE OF MRSA AS ACAUSE OF

    INFECTION AFTER OPENFRACTURES

    Shukla et al screened for MRSA colonization2473 adult patients admitted to a trauma

    ward found that the rate of MRSA surgical site

    infection was significantly higher for MRSAcarriers compared to those not colonized(8.8% vs 2.3%)

    concluded that MRSA carriers have a 2.5-times higher risk of developing postoperativeMRSA surgical site infection.

  • 8/2/2019 The Role of Prophylactic Antibiotic in MRSA

    15/19

    Beginning in 2003, major cities in the U.Shave experienced increasing rates of

    MRSA colonization and infectionoriginating in the community.

    Thiscommunity-acquired strain, frequentin patients without the classic risk factors,

    has similar virulence, resistance, andlimited treatment options as thoseoriginating in the hospital

  • 8/2/2019 The Role of Prophylactic Antibiotic in MRSA

    16/19

    Johnsonet al characterized the infections seen inconjunction with combat-associated typeIII tibialfractures.

    In this case series, 35 patients wounded in Iraq orAfghanistan who received prophylactic cefazolinand surgical debridement for an open fracture

    13 patients developed infection and delayedunion. Cultures taken from the delayed union site

    revealed S aureus in 69% of the cases(9 of 13 patients) with more than a third (4 of 13)

    due to MRSA

  • 8/2/2019 The Role of Prophylactic Antibiotic in MRSA

    17/19

    The Society for Healthcare Epidemiology of

    America in collaboration with Infectious

    Diseases Society of America published theirrecommendations to prevent surgical site

    infection in acute care hospitals.

    They highlighted the importance of prophylaxis

    against MRSA and the need for prospective trials

    looking at the addition of a glycopeptide to

    standard antibiotic prophylaxis.

  • 8/2/2019 The Role of Prophylactic Antibiotic in MRSA

    18/19

    Johnson and Johnston reported a case series of 38patients with MRSA infection

    The majority (84%) had surgical debridement andstabilization of a fracture with subsequent surgicalsite infection

    Found that orthopedic infections due to MRSAcarry extreme morbidity as a result of prolongedhospitalization, increased number of surgical

    procedures per patient, higher amputation rates,loss of musculoskeletal function, and extreme costfor both medical care and time lost fromproductive employment

  • 8/2/2019 The Role of Prophylactic Antibiotic in MRSA

    19/19

    CONCLUSION

    Antibiotic selection for prophylaxis in openfractures should be influenced by

    organism most often implicated as acause of infection.

    Selecting antibiotics active against MRSAfor open fracture prophylaxis based on

    the local prevalence of MRSA carriage,surgical site infection rates andindividualized risks factors